申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US05571810A1
公开(公告)日:1996-11-05
This invention relates to new thiophene derivatives having antiinflammatory and analgesic activities and represented by the general formula [I]: ##STR1## wherein R.sup.1 is hydrogen, halogen, cyano, substituted lower alkyl, substituted or unsubstituted lower alkenyl, acyl, nitro, substituted or unsubstituted amino, sulfo, substituted or unsubstituted sulfamoyl, N-containing heterocyclicsulfonyl, hydoxy, substituted or unsubstituted heterocyclic group, R.sup.2 is substituted or unsubstituted aryl, and R.sup.3 is substituted or unsubstituted aryl, provided that R.sup.3 is aryl substituted with substituent(s) selected from the group consisting of amino, mono(lower)-alkylamino, acylamino, lower alkyl(acyl)amino and sulfamoyl when R.sup.1 is hydrogen, halogen or cyano, and pharmaceutically acceptable salts thereof, to processes for the preparation thereof and to a pharmaceutical composition comprising the same.
这项发明涉及具有抗炎和镇痛活性的新噻吩衍生物,其通式为[I]:##STR1##其中R.sup.1为氢、卤素、氰基、取代的较低烷基、取代或未取代的较低烯基、酰基、硝基、取代或未取代的氨基、磺基、取代或未取代的磺胺基、含氮的杂环磺酰基、羟基、取代或未取代的杂环基,R.sup.2为取代或未取代的芳基,R.sup.3为取代或未取代的芳基,但要求当R.sup.1为氢、卤素或氰基时,R.sup.3为芳基,其取代物为从氨基、单(较低)烷基氨基、酰胺基、较低烷基(酰)氨基和磺胺基等组成的基团中选择的基团,以及其药学上可接受的盐,以及其制备方法和包括它们的药物组合物。